# DoD Lung Cancer, Investigator-Initiated Translational Research Award

Source: https://welltoldgrants.com/grants/w81xwh-21-lcrp-iitra-dod-lung-cancer-investigator-initiated-translational/  
Official notice: https://www.grants.gov/search-results-detail/331767

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 4 awards worth $3.8 million in total. Applications closed on July 28, 2021.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-21-LCRP-IITRA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | July 28, 2021 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 4 |
| Total funding | $3.8 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY21 LCRP Investigator-Initiated Translational Research Award mechanism supports translational research that will develop promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinician’s firsthand knowledge of patient care. The ultimate goal of translational research is to move a concept or observation forward into clinical application. However, Principal Investigators (PIs) should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between basic and clinical science. This mechanism is intended to fund a broad range of translational studies, including, but not limited to, the following: · Studies advancing/translating in vitro and/or animal studies to applications with human samples/cohorts. · Late-stage preclinical work leading to/preparing for a clinical trial, e.g., Investigational New Drug (IND) application submission. · Correlative studies that are associated with an open/ongoing or completed clinical trial and projects that develop endpoints for clinical trials.

## Questions people ask

### Is W81XWH-21-LCRP-IITRA still open?

No. It closed on July 28, 2021. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Lung Cancer, Investigator-Initiated Translational Research Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Lung Cancer, Investigator-Initiated Translational Research Award?

Closed July 28, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $3.8 million in total across about 4 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.